- Micro-Pumps
- Perfusion Pumps
Smart Implantable Pumps Market size was valued at USD 1500 million in 2022 and is expected to reach a value of USD 2621 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029 owing to increasing prevalence and incidence rate of chronic diseases coupled with growing geriatric population across the globe are the major factors driving the growth of the market. Furthermore, advancements in healthcare setup and rising number of patient population with chronic pain and other chronic diseases are expected to boost the growth of the market. For instance, in the U.S., around 20% to 30% of the population experiences chronic or recurring pain. Moreover, the rising adoption of infusion pumps or implantable pumps which are small-sized medical devices is the major factor that fuels the growth of the market over the forecast period. However, increasing product recalls and stringent regulatory policies for the approval of the products are anticipated to restrain the growth of the market. The report studies global smart implantable pumps market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global smart implantable pumps market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment hot spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global smart implantable pumps products.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The increasing aging population, specifically in developed countries such as the United States, Japan, and most of the Western Europe. Developed economies see high percent of aging compared to the emerging economies. This is indorsed to developed health care organization, promising reimbursement policies, and innovative health care facilities in developed economies. Furthermore, the heart diseases have been increasing across the globe from the past many years. For instance, the prevalence of heart failure has been increased over 5.8 million in the United States, and over 23 million across the globe.
The smart implantable pumps market size was valued at USD 187 million in 2022
The smart implantable pumps market key players are: Medtronic Cognos Therapeutics, Inc. Tricumed Medizintechnik Intarcia Therapeutics, Inc. Abbott Flowonix Medical Berlin Heart
The smart implantable pumps market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.